drugset / Trial / NCT02656849
BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
NaSingle-groupOpen-labelTreatment
Summary
This research study is studying whether a new experimental cancer study drug BAY 1000394 will be helpful in treating solid tumor cancer with an abnormality in one of the following genes: Mcl-1, Myc or CCNE.
Timeline
- Start
- 2016-02
- Primary completion
- 2019-10
- Completion
- 2023-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Roniciclib | Small molecule | — | Oral |